News | LinkedBio | LinkedBio

Stay Updated

Latest News

2026.09.10

LinkedBio and JPARTNERS Form BD·PR Partnership to Strengthen Business Development

LinkedBio, a drug development project management company, has formed a business development and PR partnership with JPARTNERS to expand external partnering. It has set up a dedicated BD·PR division and appointed Chanyoung Jang of JPARTNERS as its head.

2026.06.01

LinkedBio Marks 5th Anniversary with 9 IND Approvals, AI Platform Launch and Global Expansion

LinkedBio (CEO Sungwoon Hong), a full-cycle new drug development PM (Project Manager) specialist, announced on June 1 that it is building a proprietary AI-based platform and expanding its expert workforce to mark its 5th anniversary.

2026.02.13

LinkedBio Secures Strategic Partnership to Strengthen Clinical Development Capabilities

LinkedBio announces new strategic collaboration aimed at enhancing sponsor-sided project management services and IND-centered development strategies for pharmaceutical companies.

2024.02.06

LinkedBio and BioMarketing Lab Sign MOU for Successful Drug Development and Commercialization

LinkedBio Co., Ltd. and BioMarketing Lab have signed a mutual business agreement to provide high-quality, one-stop services for successful drug development and commercialization in the pharmaceutical and bio-healthcare sector. The partners will build cooperation across non-clinical, clinical, and commercialization stages and expand tailored sponsor support.

2022.02.10

EpiBioTek and LinkedBio Sign IND Agreement for Alopecia Cell Therapy

EpiBioTek has signed an IND agreement with LinkedBio for its autologous cell therapy EPI-001 for alopecia, with LinkedBio providing full-scope consulting from clinical trial strategy to IND approval. LinkedBio will support development strategy, documentation, and regulatory responses with a focus on IND readiness and linkage to later clinical stages.